Julian G. Westphal
Jena, TH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Liver failure as first manifestation of a hepatic lymphoma.
Journal: Zeitschrift fur Gastroenterologie
Published: March 24, 2026
Acute effects of empagliflozin on left atrial and ventricular filling parameters using echocardiography-a subanalysis of the EMPAG-HF trial.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: September 22, 2024
Effects of empagliflozin on uric acid levels during acute heart failure recompensation: A sub-analysis of the EMPAG-HF trial (Effects of Empagliflozin on Diuresis and Renal Function in Patients with Acute Decompensated Heart Failure).
Journal: European journal of heart failure
Published: September 15, 2024
Generation of human induced pluripotent stem cell lines UKJi001-A and UKJi006-A from patients with heterozygous mutation in the PKP2 gene.
Journal: Stem cell research
Published: August 06, 2024
Generation of a human induced pluripotent stem cell lines (UKJi003-A) from a patient with Fabry disease and healthy donor (UKJi004-A).
Journal: Stem cell research
Published: August 06, 2024
The Jena Method: Perfusionist Independent, Standby Wet-Primed Extracorporeal Membrane Oxygenation (ECMO) Circuit for Immediate Catheterization Laboratory and/or Hybrid Operating Room Deployment.
Journal: Journal of clinical medicine
Published: January 09, 2024
Metabolic Profiling Identifies 1-MetHis and 3-IPA as Potential Diagnostic Biomarkers for Patients With Acute and Chronic Heart Failure With Reduced Ejection Fraction.
Journal: Circulation. Heart failure
Published: January 05, 2024
Prognostic Value of Galectin-3 after Left Atrial Appendage Occlusion for Predicting Peri-Device Leakage.
Journal: International journal of molecular sciences
Published: October 31, 2023
Impact of a VA-ECMO in Combination with an Extracorporeal Cytokine Hemadsorption System in Critically Ill Patients with Cardiogenic Shock-Design and Rationale of the ECMOsorb Trial.
Journal: Journal of clinical medicine
Published: May 26, 2023
Great debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice.
Journal: European heart journal
Published: May 19, 2023
Last Updated: 09/26/2026